Logo image
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial
Journal article   Peer reviewed

Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial

Richard S E Keefe, Sophia Vinogradov, Alice Medalia, Peter F Buckley, Stanley N Caroff, Deepak C D'Souza, Phillip D Harvey, Karen A Graham, Robert M Hamer, Del D Miller, …
The journal of clinical psychiatry, Vol.73(7), pp.1016-1022
07/2012
DOI: 10.4088/jcp.11m07100
PMCID: PMC3746329
PMID: 22687548
url
https://www.ncbi.nlm.nih.gov/pmc/articles/3746329View
Open Access

Abstract

The true benefit of pharmacologic intervention to improve cognition in schizophrenia may not be evident without regular cognitive enrichment. Clinical trials assessing the neurocognitive effects of new medications may require engagement in cognitive remediation exercises to stimulate the benefit potential. However, the feasibility of large-scale multisite studies using cognitive remediation at clinical trials sites has not been established.
Feasibility Studies Psychotic Disorders - diagnosis Schizophrenia - therapy Double-Blind Method Evidence-Based Practice Humans Middle Aged Psychotic Disorders - psychology Male Treatment Outcome Schizophrenic Psychology Psychotic Disorders - therapy Neuropsychological Tests Cognition Disorders - diagnosis Pilot Projects Remedial Teaching Computer-Assisted Instruction Schizophrenia - diagnosis Adult Female Cognition Disorders - therapy Inservice Training Cognition Disorders - psychology

Details

Metrics

Logo image